Do not begin Anafranil in a patient which is being treated with linezolid or intravenous methylene blue since there is boosted risk of serotonin syndrome.
Table 4 lists unfavorable occasions that were stated in a minimum of 2 % of people in placebo-controlled trials which received Aricept as well as for which the price of occurrence was better for individuals treated regarding Aricept than with placebo.